Refine
Has Fulltext
- yes (81)
Is part of the Bibliography
- yes (81)
Year of publication
Document Type
- Journal article (78)
- Conference Proceeding (1)
- Doctoral Thesis (1)
- Report (1)
Keywords
- DNA methylation (5)
- gene expression (4)
- B cells (3)
- biodiversity (3)
- B cell receptors (2)
- CML (2)
- Candida albicans (2)
- Neisseria gonorrhoeae (2)
- apoptosis (2)
- children (2)
- density (2)
- environmental exposure (2)
- epigenetics (2)
- exome sequencing (2)
- gene (2)
- genetics (2)
- global change (2)
- land use (2)
- maternal exposure (2)
- meta-analysis (2)
- metabolism (2)
- metallic trace elements (2)
- multiple myeloma (2)
- network analysis (2)
- prenatal exposure (2)
- psychiatry (2)
- risk factors (2)
- transcriptome (2)
- (classical and atypical) Werner syndrome (1)
- 3D modeling (1)
- ABCG2 (1)
- AcrAB-TolC efflux pump (1)
- Adult (1)
- Affenimmundefizienzvirus (1)
- Alpha therapy (1)
- Alzheimer's disease (1)
- Aspergillus fumigatus (1)
- Autism (1)
- Autism spectrum disorders (1)
- Autoimmune diseases (1)
- BCR‐ABL (1)
- BETA-Diversität (1)
- BETA-Multifunktionalität (1)
- BM (1)
- BMP (1)
- BRAF(V600E) mutation (1)
- Biodiversität (1)
- Biomarker (1)
- Biomedical engineering (1)
- Bone marrow transplantantation (1)
- CD8+ T cells (1)
- CDC14A (1)
- CIS+ (1)
- CRC (1)
- CXCR4 (1)
- ChIPseq (1)
- Chirurgie (1)
- Chlamydia pneumoniae (1)
- Class II antigen blockade (1)
- Computersimulation (1)
- Cortex (1)
- DEL(5Q) (1)
- DFNB32 (1)
- DFNB68 (1)
- DNA damage (1)
- DNA methylation dynamics (1)
- Dendritische Zelle (1)
- Dickkopf proteins (1)
- Down syndrome (1)
- Dreidimensionales Modell (1)
- EZH1 (1)
- EZH2 (1)
- Entrepreneurship (1)
- Environment (1)
- Epigenetics (1)
- Escherichia coli (1)
- Expression (1)
- Factor receptor (1)
- Fetal brain development (1)
- Finite Element Simulationen (1)
- Finite Element Simulations (1)
- Finite-Elemente-Methode (1)
- First G-APD Cherenkov Telescope (1)
- Forschungsstation Fabrikschleichach (1)
- Frontal cortex (1)
- Functional modules (1)
- GRAID (1)
- Gefügekunde (1)
- Gene-expression (1)
- Genome (1)
- Germany (1)
- Graft-versus-leukemia (1)
- H3K27me3 (1)
- Head (1)
- Human prefrontal cortex (1)
- IL-12B (1)
- IL-12p40 (1)
- IL12B (1)
- Imaging Air Cherenkov Telescope (1)
- Imatinib (1)
- Immunstimulation (1)
- Impedance Spectroscopy (1)
- Impedanzspektroskopie (1)
- Innovationsforschung (1)
- Innovationsmanagement (1)
- Innovationspotenzial (1)
- Integrated network analysis (1)
- Keramischer Werkstoff (1)
- LAMN (1)
- LASP1 (1)
- LND (1)
- LNE (1)
- LRP6 (1)
- LST (1)
- M1/M2 macrophages (1)
- MDS (1)
- MDSC (1)
- MITE (1)
- Metabolic pathways (1)
- Metabolic profiles (1)
- Methylome (1)
- Microstructure Modelling (1)
- Microstructure–Property–Relationship (1)
- Mikrostruktur (1)
- Mikrostrukturmodellierung (1)
- Mikrostruktur–Eigenschafts–Korrelationen (1)
- Milnesium tardigradum (1)
- Monoclonal antibody (1)
- Munigua (1)
- NDVI thresholds (1)
- NFATc1 (1)
- OPUS (1)
- PTCL (1)
- Pakistan (1)
- Partner für Innovation (1)
- Patterns (1)
- Prediction (1)
- Produktinnovation (1)
- RNA (1)
- RNA extraction (1)
- Regulatory-cells (1)
- Rhabdomyosarcoma (1)
- Rheumatoid arthritis (1)
- S1PR2 (1)
- SSI (1)
- Schizophrenia (1)
- Simulation (1)
- Sozialinnovation (1)
- Spindle cell (1)
- Staphylococcus aureus (1)
- Stem-cell biotechnology (1)
- Suicidal behavior (1)
- Suppression (1)
- Surgery (1)
- T cells (1)
- T-cell non-Hodgkin's lymphomas (1)
- TH1-induced senescence (1)
- TH17 cells (1)
- TIC disorders (1)
- TNFR2 (1)
- TP53 mutations (1)
- Technische Innovation (1)
- Transcription (1)
- Transcription regulation (1)
- Trend test (1)
- Tumor-necrosis-factor (1)
- UAV (1)
- Universität (1)
- WNT (1)
- Waldökosystem (1)
- Wirtschaft (1)
- Würzburg (1)
- ZfKD (1)
- action potential (1)
- adaption (1)
- adrenal cancer (1)
- adrenocortical carcinoma (1)
- agricultural mapping (1)
- alignment (1)
- alu elements (1)
- alzheimers disease (1)
- amino acid transporter (1)
- androgen deprivation therapy (1)
- antagonist (1)
- antibiotic resistance (1)
- antibodies (1)
- ants (1)
- apolipoprotein-E4 (1)
- appendectomy (1)
- appendicitis (1)
- appendix (1)
- aspergillus fumigatus (1)
- association (1)
- atmospheric correction (1)
- atypical tetracyclines (1)
- autism (1)
- autoantibodies (1)
- autosomal recessive hearing loss (1)
- autosomal recessive non-synstromic hearing loss (1)
- azacitidine (1)
- beta diversity (1)
- beta-diversity (1)
- beta-multifunctionality (1)
- betaglycan (1)
- bioinformatics and computational biology (1)
- bipartite metabolism (1)
- bisulfite pyrosequencing (1)
- bohemian forest ecosystem (1)
- bone (1)
- brain (1)
- brain metastases (1)
- broad-spectrum antibiotics (1)
- cancer (1)
- cancer treatment (1)
- cancer-targeted IL-12 (1)
- candida genome database (1)
- cell binding (1)
- cell cycle and cell division (1)
- cell death (1)
- cell metabolism (1)
- cell proliferation (1)
- cell wall (1)
- cells (1)
- cerebral metastases (1)
- channelrhodopsin (1)
- chelocardins (1)
- climate change (1)
- clinical isolates (1)
- cluster (1)
- cochlear implant (1)
- coding strategy (1)
- coleoptera (1)
- colorectal cancer (1)
- common SNPS (1)
- community data (1)
- complex diseases (1)
- computational prediction (1)
- consanguinity (1)
- conventional laparoscopic appendectomy (1)
- coprophagous beetles (1)
- coreceptor (1)
- costimulation (1)
- cryptic (1)
- crystal structure (1)
- cytokine (1)
- cytotoxicity (1)
- dass II antigen blockade (1)
- data acquisition (1)
- data pool (1)
- deadwood (1)
- decay (1)
- decomposition (1)
- delayed rectifier potassium channel (1)
- denritic cells (1)
- differentiation (1)
- disease (1)
- dissection (1)
- distant metastases (1)
- dual guidance (1)
- echo planar imaging (1)
- ecology (1)
- economics (1)
- ecosystem function (1)
- ecosystem functioning (1)
- elderly (1)
- emissivity (1)
- entrepreneurship (1)
- enzyme-linked immunoassays (1)
- epidemiology (1)
- epigenetics in the nervous system (1)
- epigenomics (1)
- epithelial cells (1)
- essential tremor (1)
- evolution (1)
- expressed sequence tag (1)
- expression (1)
- extracellular vesicle (1)
- family (1)
- fear conditioning (1)
- fetal brain development (1)
- fetal cord blood (1)
- fetal programming (1)
- fibroblasts (1)
- fine structure processing (1)
- flippase (1)
- force (1)
- forest degradation (1)
- forest ecosystem science (1)
- frameshift (1)
- frontal cortex (1)
- functional magnetic resonance imaging (1)
- functional modules (1)
- gene regulation (1)
- genetic diagnosis (1)
- genetic variation (1)
- genome-wide association study (1)
- genome-wide linkage analysis (1)
- geomorphology (1)
- gestational diabetes mellitus (1)
- gilles (1)
- glycoprotein (1)
- gradients (1)
- growth and differentiation factor 5 (1)
- growth factor beta (1)
- guidelines (1)
- hERG (1)
- hearing loss (1)
- heart (1)
- heart failure (1)
- heterologous (1)
- hill numbers (1)
- homology modeling (1)
- host cells (1)
- humanized mice (1)
- hypthesis (1)
- imaging techniques (1)
- immune receptors (1)
- immune regulation (1)
- immune response (1)
- immunocytokine (1)
- immunohistochemistry (1)
- immunotherapy (1)
- increases bone-formation (1)
- inflammation (1)
- innovation (1)
- insect monitoring (1)
- insects (1)
- insulin treatment (1)
- internal transcribed spacer 2 (1)
- interolog (1)
- juvenile idiopathic arthritis (1)
- karyotype (1)
- kidneys (1)
- kinase signaling (1)
- land-use intensification (1)
- learning (1)
- ligand (1)
- ligand binding (1)
- ligand-receptor complex (1)
- lipid asymmetry (1)
- long QT syndrome (1)
- long-term monitoring (1)
- low-cost applications (1)
- low-grade mucinous neoplasm (1)
- lymph node dissection (1)
- lymph node metastases (1)
- lymphadenectomy (1)
- macrophages (1)
- management (1)
- matched filters (1)
- mechanism of resistance (1)
- medial prefrontal cortex (mPFC) (1)
- membrane receptor signaling (1)
- memory B cells (1)
- memory consolidation and extinction (1)
- metastasis-directed therapy (1)
- methylation (1)
- methylation array (1)
- micro-CT (1)
- missing heritability (1)
- mixed hearing loss (1)
- molecular cloning (1)
- molecular medicine (1)
- molecular systematics (1)
- movement disorders (1)
- multiresistance (1)
- multispectral VNIR (1)
- multi‑center cohort study (1)
- muscle (1)
- music (1)
- mutagenesis (1)
- near-infrared spectroscopy (1)
- necrobiome (1)
- necrotic cell death (1)
- neisseria meningitidis (1)
- neonates (1)
- network inference (1)
- neurodegeneration (1)
- neurogenesis (1)
- neurological disorders (1)
- neuroprotection (1)
- neuropsychiatric disorders (1)
- neutrophils (1)
- next generation sequencing (1)
- nilotinib (1)
- non-sense mediated mRNA decay (1)
- oligmometastases (1)
- oligorecurrence (1)
- optogenetics (1)
- osteoporosis (1)
- oxidative stress (1)
- p53 expression (1)
- papillary (1)
- passes (1)
- pathogen-host interaction (PHI) (1)
- pathogenicity (1)
- persistence (1)
- phagocytosis (1)
- phosphatidylethanolamine (1)
- phosphatidylserine (1)
- phosphoproteome (1)
- phylogenetic tree (1)
- phylogeny (1)
- pitch (1)
- polymerization (1)
- polymorphism (1)
- postmenopausal osteoporosis (1)
- posttranscriptional regulation (1)
- potential role (1)
- precursor cells (1)
- premature aging (1)
- primary biliary cholangitis (1)
- prognosis (1)
- promoter (1)
- prostate cancer (1)
- protein familiy (1)
- protein interaction database (1)
- protein-protein interaction (1)
- proteins (1)
- protocadherin gamma cluster (1)
- quality-control (1)
- radiation therapy (1)
- radioiodine therapy (1)
- rare diseases (1)
- rat (1)
- rat model (1)
- receptor (1)
- receptor type III (1)
- regulatory T cell (1)
- relA (1)
- remote sensing (1)
- remote sensing‐enabled essential biodiversity variables (1)
- renal transplantation (1)
- repair (1)
- repulsive guidance molecule A (1)
- resistance-breaking properties (1)
- review (1)
- rhabdomyosarcoma (1)
- ribosomal RNA (1)
- sRNA (1)
- scoring system (1)
- second line therapy (1)
- secondary structure (1)
- segmental progeria (1)
- serum (1)
- signal filtering (1)
- signaling (1)
- silicon photo multiplier (1)
- single-port appendectomy (1)
- sky kinases (1)
- space-for-time approach (1)
- spatial scales (1)
- speech perception (1)
- splicing (1)
- statistical data (1)
- stereotactic body radiotherapy (1)
- stringent response (1)
- study design (1)
- superfamily (1)
- surgery (1)
- surgical site infection (1)
- systematic review (1)
- systems biology (1)
- tardigrada (1)
- thermal infrared (1)
- tool (1)
- training (1)
- transcranial magnetic stimulation (TMS) (1)
- transcription deficiency (1)
- transcriptional regulation (1)
- transmission (1)
- transplantation (1)
- transposable elements (1)
- treatment response (1)
- tremor (1)
- trisomy 21 (1)
- tumor-infiltrating lymphocytes (1)
- urbanization (1)
- urinary tract infection (UTI) (1)
- uropathogens (1)
- ursodeoxycholic acid (1)
- verbal fluency task (1)
- very high energy gamma rays (1)
- virulenceregulatory evolution (1)
- vision (1)
- voltage-gated Na\(^+\) channel (1)
- whole exome sequencing (1)
- wound infection (1)
Institute
- Theodor-Boveri-Institut für Biowissenschaften (33)
- Institut für Humangenetik (12)
- Institut für Virologie und Immunbiologie (7)
- Julius-von-Sachs-Institut für Biowissenschaften (7)
- Medizinische Klinik und Poliklinik II (7)
- Kinderklinik und Poliklinik (6)
- Klinik und Poliklinik für Allgemein-, Viszeral-, Gefäß- und Kinderchirurgie (Chirurgische Klinik I) (6)
- Institut für Geographie und Geologie (5)
- Klinik und Poliklinik für Psychiatrie, Psychosomatik und Psychotherapie (5)
- Lehrstuhl für Tissue Engineering und Regenerative Medizin (5)
Sonstige beteiligte Institutionen
- Albert-Ludwigs-Universität Freiburg (1)
- Fraunhofer-Institut für Silcatforschung ISC in Würzburg (1)
- Goethe-Universität Frankfurt (1)
- Leuphana Universität Lüneburg (1)
- Technische Universität Dresden (1)
- Technische Universität München (1)
- Universität Bayreuth (1)
- Universität Göttingen (1)
- Universität Leipzig (1)
- iDiv (1)
Climate and land-use change are key drivers of environmental degradation in the Anthropocene, but too little is known about their interactive effects on biodiversity and ecosystem services. Long-term data on biodiversity trends are currently lacking. Furthermore, previous ecological studies have rarely considered climate and land use in a joint design, did not achieve variable independence or lost statistical power by not covering the full range of environmental gradients.
Here, we introduce a multi-scale space-for-time study design to disentangle effects of climate and land use on biodiversity and ecosystem services. The site selection approach coupled extensive GIS-based exploration (i.e. using a Geographic information system) and correlation heatmaps with a crossed and nested design covering regional, landscape and local scales. Its implementation in Bavaria (Germany) resulted in a set of study plots that maximise the potential range and independence of environmental variables at different spatial scales.
Stratifying the state of Bavaria into five climate zones (reference period 1981–2010) and three prevailing land-use types, that is, near-natural, agriculture and urban, resulted in 60 study regions (5.8 × 5.8 km quadrants) covering a mean annual temperature gradient of 5.6–9.8°C and a spatial extent of ~310 × 310 km. Within these regions, we nested 180 study plots located in contrasting local land-use types, that is, forests, grasslands, arable land or settlement (local climate gradient 4.5–10°C). This approach achieved low correlations between climate and land use (proportional cover) at the regional and landscape scale with |r ≤ 0.33| and |r ≤ 0.29| respectively. Furthermore, using correlation heatmaps for local plot selection reduced potentially confounding relationships between landscape composition and configuration for plots located in forests, arable land and settlements.
The suggested design expands upon previous research in covering a significant range of environmental gradients and including a diversity of dominant land-use types at different scales within different climatic contexts. It allows independent assessment of the relative contribution of multi-scale climate and land use on biodiversity and ecosystem services. Understanding potential interdependencies among global change drivers is essential to develop effective restoration and mitigation strategies against biodiversity decline, especially in expectation of future climatic changes. Importantly, this study also provides a baseline for long-term ecological monitoring programs.
Stimulating the immune system to attack cancer is a promising approach, even for the control of advanced cancers. Several cytokines that promote interferon-γ-dominated immune responses show antitumor activity, with interleukin 12 (IL-12) being of major importance. Here, we used an antibody-IL-12 fusion protein (NHS-IL12) that binds histones of necrotic cells to treat human sarcoma in humanized mice. Following sarcoma engraftment, NHS-IL12 therapy was combined with either engineered IL-7 (FcIL-7) or IL-2 (IL-2MAB602) for continuous cytokine bioavailability. NHS-IL12 strongly induced innate and adaptive antitumor immunity when combined with IL-7 or IL-2. NHS-IL12 therapy significantly improved survival of sarcoma-bearing mice and caused long-term remissions when combined with IL-2. NHS-IL12 induced pronounced cancer cell senescence, as documented by strong expression of senescence-associated p16\(^{INK4a}\) and nuclear translocation of p-HP1γ, and permanent arrest of cancer cell proliferation. In addition, this cancer immunotherapy initiated the induction of myogenic differentiation, further promoting the hypothesis that efficient antitumor immunity includes mechanisms different from cytotoxicity for efficient cancer control in vivo.
Rhesus monkeys (M. mulatta) were i. v. infected with SIV mac251. Three phases of lymph node changes were observed. 1: physiological follicular hyperplasia (3 and 6 weeks p.i.). 2: Alterations of germinal centers: loss of follicular mantle zone, fragmentation or sclerosis (12 and 24 weeks p.i.). 3: Partial depletion of T-lymphocytes, accumulation of plasma cells, increased numbers of syncytial giant cells, hemophgocytosis in the sinuses (about 1 year p.i.). The thymus of the juvenile animals showed first changes 12 and 24 weeks after infection with focalloss of immature (and Ki-67 positive) cortical thymocytes, leading to severe accidental involution of the thymuses one year after infection and reduced numbers of Hassalls corpuscles. These investigations show the value of this animal model for the study of morphology and pathogenesis of AIDS.
Multiple myeloma (MM), a malignancy of the bone marrow, is characterized by a pathological increase in antibody-producing plasma cells and an increase in immunoglobulins (plasmacytosis). In recent years, bone morphogenetic proteins (BMPs) have been reported to be activators of apoptotic cell death in neoplastic B cells in MM. Here, we use bone morphogenetic protein 2 (BMP2) to show that the "apoptotic" effect of BMPs on human neoplastic B cells is dominated by anti-proliferative activities and cell cycle arrest and is apoptosis-independent. The anti-proliferative effect of BMP2 was analysed in the human cell lines KMS12-BM and L363 using WST-1 and a Coulter counter and was confirmed using CytoTox assays with established inhibitors of programmed cell death (zVAD-fmk and necrostatin-1). Furthermore, apoptotic activity was compared in both cell lines employing western blot analysis for caspase 3 and 8 in cells treated with BMP2 and FasL. Additionally, expression profiles of marker genes of different cell death pathways were analysed in both cell lines after stimulation with BMP2 for 48h using an RT-PCR-based array. In our experiments we observed that there was rather no reduction in absolute cell number, but cells stopped proliferating following treatment with BMP2 instead. The time frame (48–72 h) after BMP2 treatment at which a reduction in cell number is detectable is too long to indicate a directly BMP2-triggered apoptosis. Moreover, in comparison to robust apoptosis induced by the approved apoptotic factor FasL, BMP2 only marginally induced cell death. Consistently, neither the known inhibitor of apoptotic cell death zVAD-fmk nor the necroptosis inhibitor necrostatin-1 was able to rescue myeloma cell growth in the presence of BMP2.
Multiple myeloma (MM) represents a haematological cancer characterized by the pathological hyper proliferation of antibody-producing B-lymphocytes. Patients typically suffer from kidney malfunction and skeletal disorders. In the context of MM, the transforming growth factor β (TGFβ) member Activin A was recently identified as a promoter of both accompanying symptoms. Because studies have shown that bone morphogenetic protein (BMP)-2-mediated activities are counteracted by Activin A, we analysed whether BMP2, which also binds to the Activin A receptors ActRII and ActRIIB but activates the alternative SMAD-1/5/8 pathway, can be used to antagonize Activin A activities, such as in the context of MM. Therefore three BMP2 derivatives were generated with modified binding activities for the type II (ActRIIB) and/or type I receptor (BMPRIA) showing either increased or decreased BMP2 activity. In the context of MM these BMP2 muteins show two functionalities since they act as a) an anti-proliferative/apoptotic agent against neoplastic B-cells, b) as a bone-formation promoting growth factor. The molecular basis of both activities was shown in two different cellular models to clearly rely on the properties of the investigated BMP2 muteins to compete for the binding of Activin A to the Activin type II receptors. The experimental outcome suggests new therapeutic strategies using BMP2 variants in the treatment of MM-related pathologies.
T-cell lymphomas are highly heterogeneous and their prognosis is poor under the currently available therapies. Enhancers of zeste homologue 1 and 2 (EZH1/2) are histone H3 lysine-27 trimethyltransferases (H3K27me3). Despite the rapid development of new drugs inhibiting EZH2 and/or EZH1, the molecular interplay of these proteins and the impact on disease progression and prognosis of patients with T-cell lymphomas remains insufficiently understood. In this study, EZH1/2 mutation status was evaluated in 33 monomorphic epitheliotropic intestinal T-cell lymphomas by next generation sequencing and EZH1/2 and H3K27me3 protein expression levels were detected by immunohistochemistry in 46 T-cell lymphomas. Correlations with clinicopathologic features were analyzed and survival curves generated. No EZH1 mutations and one (3%) EZH2 missense mutation were identified. In univariable analysis, high EZH1 expression was associated with an improved overall survival (OS) and progression-free survival (PFS) whereas high EZH2 and H3K27me3 expression were associated with poorer OS and PFS. Multivariable analysis revealed EZH1 (hazard ratio (HR) = 0.183; 95% confidence interval (CI): 0.044–0.767; p = 0.020;) and EZH2 (HR = 8.245; 95% CI: 1.898–35.826; p = 0.005) to be independent, divergent prognostic markers for OS. In conclusion, EZH1/2 protein expression had opposing effects on the prognosis of T-cell lymphoma patients.
Chronic myeloid leukaemia (CML) is a clonal myeloproliferative stem cell disorder characterized by the constitutively active BCR‐ABL tyrosine kinase. The LIM and SH3 domain protein 1 (LASP1) has recently been identified as a novel BCR‐ABL substrate and is associated with proliferation, migration, tumorigenesis and chemoresistance in several cancers. Furthermore, LASP1 was shown to bind to the chemokine receptor 4 (CXCR4), thought to be involved in mechanisms of relapse. In order to identify potential LASP1‐mediated pathways and related factors that may help to further eradicate minimal residual disease (MRD), the effect of LASP1 on processes involved in progression and maintenance of CML was investigated. The present data indicate that not only overexpression of CXCR4, but also knockout of LASP1 contributes to proliferation, reduced apoptosis and migration as well as increased adhesive potential of K562 CML cells. Furthermore, LASP1 depletion in K562 CML cells leads to decreased cytokine release and reduced NK cell‐mediated cytotoxicity towards CML cells. Taken together, these results indicate that in CML, reduced levels of LASP1 alone and in combination with high CXCR4 expression may contribute to TKI resistance.
Objectives: To assess the subjective and objective performance of the new fine structure processing strategy (FSP) compared to the previous generation coding strategies CIS+ and HDCIS. Methods: Forty-six adults with a minimum of 6 months of cochlear implant experience were included. CIS+, HDCIS and FSP were compared in speech perception tests in noise, pitch scaling and questionnaires. The randomized tests were performed acutely (interval 1) and again after 3 months of FSP experience (interval 3). The subjective evaluation included questionnaire 1 at intervals 1 and 3, and questionnaire 2 at interval 2, 1 month after interval 1. Results: Comparison between FSP and CIS+ showed that FSP performed at least as well as CIS+ in all speech perception tests, and outperformed CIS+ in vowel and monosyllabic word discrimination. Comparison between FSP and HDCIS showed that both performed equally well in all speech perception tests. Pitch scaling showed that FSP performed at least as well as HDCIS. With FSP, sound quality was at least as good and often better than with HDCIS. Conclusions: Results indicate that FSP performs better than CIS+ in vowel and monosyllabic word understanding. Subjective evaluation demonstrates strong user preferences for FSP when listening to speech and music.
The direct estimation of heritability from genome-wide common variant data as implemented in the program Genome-wide Complex Trait Analysis (GCTA) has provided a means to quantify heritability attributable to all interrogated variants. We have quantified the variance in liability to disease explained by all SNPs for two phenotypically-related neurobehavioral disorders, obsessive-compulsive disorder (OCD) and Tourette Syndrome (TS), using GCTA. Our analysis yielded a heritability point estimate of 0.58 (se = 0.09, p = 5.64e-12) for TS, and 0.37 (se = 0.07, p = 1.5e-07) for OCD. In addition, we conducted multiple genomic partitioning analyses to identify genomic elements that concentrate this heritability. We examined genomic architectures of TS and OCD by chromosome, MAF bin, and functional annotations. In addition, we assessed heritability for early onset and adult onset OCD. Among other notable results, we found that SNPs with a minor allele frequency of less than 5% accounted for 21% of the TS heritability and 0% of the OCD heritability. Additionally, we identified a significant contribution to TS and OCD heritability by variants significantly associated with gene expression in two regions of the brain (parietal cortex and cerebellum) for which we had available expression quantitative trait loci (eQTLs). Finally we analyzed the genetic correlation between TS and OCD, revealing a genetic correlation of 0.41 (se = 0.15, p = 0.002). These results are very close to previous heritability estimates for TS and OCD based on twin and family studies, suggesting that very little, if any, heritability is truly missing (i.e., unassayed) from TS and OCD GWAS studies of common variation. The results also indicate that there is some genetic overlap between these two phenotypically-related neuropsychiatric disorders, but suggest that the two disorders have distinct genetic architectures.
Despite recent therapeutic advances the prognosis of heart failure remains poor. Recent research suggests that heart failure is a heterogeneous syndrome and that many patients have stimulating auto-antibodies directed against the second extracellular loop of the \(β_1\) adrenergic receptor \((β_1EC2)\). In a human-analogous rat model such antibodies cause myocyte damage and heart failure. Here we used this model to test a novel antibody-directed strategy aiming to prevent and/or treat antibody-induced cardiomyopathy. To generate heart failure, we immunised n = 76/114 rats with a fusion protein containing the human β1EC2 (amino-acids 195–225) every 4 weeks; n = 38/114 rats were control-injected with 0.9% NaCl. Intravenous application of a novel cyclic peptide mimicking \(β_1EC2\) (\(β_1EC2-CP\), 1.0 mg/kg every 4 weeks) or administration of the \(β_1-blocker\) bisoprolol (15 mg/kg/day orally) was initiated either 6 weeks (cardiac function still normal, prevention-study, n = 24 (16 treated vs. 8 untreated)) or 8.5 months after the 1st immunisation (onset of cardiomyopathy, therapy-study, n = 52 (40 treated vs. 12 untreated)); n = 8/52 rats from the therapy-study received \(β_1EC2-CP/bisoprolol\) co-treatment. We found that \(β_1EC2-CP\) prevented and (alone or as add-on drug) treated antibody-induced cardiac damage in the rat, and that its efficacy was superior to mono-treatment with bisoprolol, a standard drug in heart failure. While bisoprolol mono-therapy was able to stop disease-progression, \(β_1EC2-CP\) mono-therapy -or as an add-on to bisoprolol- almost fully reversed antibody-induced cardiac damage. The cyclo¬peptide acted both by scavenging free \(anti-β_1EC2-antibodies\) and by targeting \(β_1EC2\)-specific memory B-cells involved in antibody-production. Our model provides the basis for the clinical translation of a novel double-acting therapeutic strategy that scavenges harmful \(anti-β_1EC2-antibodies\) and also selectively depletes memory B-cells involved in the production of such antibodies. Treatment with immuno-modulating cyclopeptides alone or as an add-on to \(β_1\)-blockade represents a promising new therapeutic option in immune-mediated heart failure.